Parents' and providers' attitudes toward school-located provision and school-entry requirements for HPV vaccines
- PMID: 26934421
- PMCID: PMC4964627
- DOI: 10.1080/21645515.2016.1140289
Parents' and providers' attitudes toward school-located provision and school-entry requirements for HPV vaccines
Abstract
Objective: To determine parents' and providers' attitudes toward school-located provision and school-entry requirements for HPV vaccination.
Methods: Parents/guardians of 11-17 y old girls and pediatric healthcare providers at one inner-city public clinic and three private practices completed semi-structured interviews in 2012-2013. Participants were asked open-ended questions regarding their attitudes toward school-located provision and school-entry requirements for HPV vaccination. Parents' answers were analyzed with relationship to whether their daughters had not initiated, initiated but not completed, or completed the HPV vaccine series. Qualitative analysis was used to identify themes related to shared views.
Results: 129 parents/guardians and 34 providers participated. 61% of parents supported providing HPV vaccinations in schools, citing reasons of convenience, improved access, and positive peer pressure. Those who opposed school-located provision raised concerns related to privacy and the capacity of school nurses to manage vaccine-related reactions. Parents whose daughters had not completed the series were more likely to intend to vaccinate their daughters in schools (70%) and support requirements (64%) than parents who had not initiated vaccination (42% would vaccinate at school, 46% support requirements) or completed the series (42% would vaccinate at school, 32% support requirements; p < 0 .05 for all comparisons). 81% of providers supported offering vaccination in schools, wanting to take advantage of the captive audience, improve vaccine completion rates, and decrease the administrative burden on medical office staff, but were concerned about adequate information transfer between schools and medical offices. Only 32% of providers supported school-entry requirements, largely because they felt that a requirement might provoke a public backlash that could further hinder vaccination efforts.
Conclusions: School-located provision of HPV vaccination was widely accepted by healthcare providers and parents whose children have not completed the series, indicating that this venue might be a valuable addition to improve completion rates. Support for school-entry requirements was limited among both parents and healthcare providers.
Keywords: HPV vaccination; parents attitudes; provider attitudes; school located immunizations; school-entry vaccine requirements; vaccine mandates.
Similar articles
-
Understanding parents' views toward the newly enacted HPV vaccine school entry policy in Puerto Rico: a qualitative study.BMC Public Health. 2021 Oct 25;21(1):1938. doi: 10.1186/s12889-021-11952-w. BMC Public Health. 2021. PMID: 34696745 Free PMC article.
-
Why don't adolescents finish the HPV vaccine series? A qualitative study of parents and providers.Hum Vaccin Immunother. 2016 Jun 2;12(6):1528-35. doi: 10.1080/21645515.2015.1118594. Epub 2016 Jan 25. Hum Vaccin Immunother. 2016. PMID: 26810765 Free PMC article.
-
Opinions of parents about school-entry mandates for the human papillomavirus vaccine.J Low Genit Tract Dis. 2010 Jan;14(1):43-8. doi: 10.1097/LGT.0b013e3181b0fad4. J Low Genit Tract Dis. 2010. PMID: 20040835
-
Improving adolescent health: focus on HPV vaccine acceptance.J Adolesc Health. 2005 Dec;37(6 Suppl):S17-23. doi: 10.1016/j.jadohealth.2005.09.010. J Adolesc Health. 2005. PMID: 16310137 Review.
-
The uptake of Human Papillomavirus (HPV) vaccine among adolescent females in the United States: a review of the literature.J Sch Nurs. 2011 Dec;27(6):434-46. doi: 10.1177/1059840511415861. Epub 2011 Jul 12. J Sch Nurs. 2011. PMID: 21750234 Review.
Cited by
-
Stated preferences for human papillomavirus vaccination for adolescents in selected communities in Ibadan, Southwest Nigeria: A discrete choice experiment.Hum Vaccin Immunother. 2022 Nov 30;18(6):2124091. doi: 10.1080/21645515.2022.2124091. Epub 2022 Nov 16. Hum Vaccin Immunother. 2022. PMID: 36383765 Free PMC article.
-
Implementation of the human papillomavirus school-entry requirement in Puerto Rico: barriers and facilitators using the consolidated framework for implementation research.Hum Vaccin Immunother. 2021 Nov 2;17(11):4423-4432. doi: 10.1080/21645515.2021.1955609. Epub 2021 Aug 9. Hum Vaccin Immunother. 2021. PMID: 34369857 Free PMC article.
-
Effects of a multidisciplinary team-led school-based human papillomavirus vaccination health-promotion programme on improving vaccine acceptance and uptake among female adolescents: A cluster randomized controlled trial.Medicine (Baltimore). 2020 Sep 11;99(37):e22072. doi: 10.1097/MD.0000000000022072. Medicine (Baltimore). 2020. PMID: 32925744 Free PMC article. Clinical Trial.
-
Improving United States HPV vaccination rates: Factors predictive of parental attitudes towards middle school entry requirements.Hum Vaccin Immunother. 2024 Dec 31;20(1):2390231. doi: 10.1080/21645515.2024.2390231. Epub 2024 Sep 13. Hum Vaccin Immunother. 2024. PMID: 39268680 Free PMC article.
-
Social Ecological Influences on HPV Vaccination Among Cape Verdean Immigrants in the U. S.: A Qualitative Study.Vaccines (Basel). 2025 Jun 30;13(7):713. doi: 10.3390/vaccines13070713. Vaccines (Basel). 2025. PMID: 40733690 Free PMC article.
References
-
- Reagan-Steiner S, Yankey D, Jeyarajah J, et al.. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2014. MMWR Morb Mortal Wkly Rep July 31 2015; 64(29):784-792; PMID:26225476; http://dx.doi.org/10.15585/mmwr.mm6429a3 - DOI - PMC - PubMed
-
- Garland SM. The Australian experience with the human papillomavirus vaccine. Clin Ther January 1 2014; 36(1):17-23; PMID:24417782; http://dx.doi.org/10.1016/j.clinthera.2013.12.005 - DOI - PubMed
-
- Lim WT, Sears K, Smith LM, Liu G, Levesque LE. Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study. BMC Public Health 2014; 14:1029; PMID:25278003; http://dx.doi.org/10.1186/1471-2458-14-1029 - DOI - PMC - PubMed
-
- Stretch R. Implementing a school-based HPV vaccination programme. Nurs Times December 2–8 2008; 104(48):30-33; PMID:19090363 - PubMed
-
- Ali H, Donovan B, Wand H, et al.. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. Bmj 2013; 346:f2032; PMID:23599298; http://dx.doi.org/10.1136/bmj.f2032 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical